CIM
AZN icon

Capital Investment Management’s AstraZeneca AZN Stock Holding History

Capital Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361K Sell
1,905
-31
-2% -$5.83K 0.11% 92
2026
Q1 		$382K Sell
1,936
-96
-5% -$18.5K 0.13% 86
2025
Q4 		$373K Buy
+2,032
New +$356K 0.13% 83

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Capital Investment Management's AZN Position: Q2 2026 in Review

Capital Investment Management reduced its AstraZeneca (AZN) stake by 1.6% in Q2 2026, selling an estimated $5.83K and leaving 1,905 shares worth $361K. The position accounts for 0.11% of the portfolio, ranked #92.

Capital Investment Management first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $382K in Q1 2026. 487 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Capital Investment Management held 1,905 shares of AstraZeneca worth $361K as of Q2 2026.
  • Capital Investment Management sold 31 AstraZeneca shares in Q2 2026, an estimated $5.83K.
  • AstraZeneca made up 0.11% of Capital Investment Management's portfolio in Q2 2026, its #92 holding.
  • Capital Investment Management first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • Capital Investment Management's AstraZeneca position peaked at $382K in Q1 2026.
  • 487 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Capital Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.